KeyVex › Disclosures › Congressional trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

Doug Lamborn (House) disclosed 5 transactions

· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk

Amendment status is not available for House filings. A filing listed here may since have been amended.

2017-01-24 · buyInnate Immunotherapeutics — $15,001 - $50,000
2017-01-24 · sellNetApp, Inc. shares — $15,001 - $50,000
2017-01-24 · buyInnate Immunotherapeutics — $15,001 - $50,000
2017-01-24 · sellNetApp, Inc. shares — $15,001 - $50,000
2017-01-24 · sellNetApp, Inc. sale of February calls at 37.5 — $1,001 - $15,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

ownerSpouse
partyRepublican
stateCO
officeLamborn, Doug (Representative)
ptr id9110463
chamberhouse
report urlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2017/9110463.pdf
bioguide idL000564
data sourceHOUSE_CLERK_PTR
member lastLamborn
member nameDoug Lamborn
member firstDoug
state districtCO05
disclosure date2017-02-15
transaction date2017-01-24
extraction methodvision_ocr
reporting lag days16

Each transaction (5)

idtickercommentamount maxamount minasset nameasset typeamount rangetransaction type
house-9110463-ocr-5—IRA5000015001Innate ImmunotherapeuticsStock$15,001 - $50,000buy
house-9110463-ocr-4NTAPIRA5000015001NetApp, Inc. sharesStock$15,001 - $50,000sell
house-9110463-ocr-3—IRA5000015001Innate ImmunotherapeuticsStock$15,001 - $50,000buy
house-9110463-ocr-2NTAPIRA5000015001NetApp, Inc. sharesStock$15,001 - $50,000sell
house-9110463-ocr-1NTAP@37.5150001001NetApp, Inc. sale of February calls at 37.5Option$1,001 - $15,000sell

Original filing document